Abstract:Although many genetic variants related to anti-tuberculosis drug induced liver injury (ATDILI) have been identified, the prediction and personalized treatment of ATDILI have failed to achieve, indicating there remains an area for further exploration. This study aimed to explore the influence of single nucleotide polymorphisms (SNPs) in Bradykinin receptor B2 (BDKRB2), Teneurin transmembrane protein 2 (TENM2), transforming growth factor beta 2 (TGFB2), and solute carrier family 2 member 13 (SLC2A13) on the risk of ATDILI. The subjects comprised 746 Chinese tuberculosis (TB) patients. Custom-by-design 2x48-Plex SNPscanTM kit was employed to genotype 28 selected SNPs. The associations of SNPs with ATDILI risk and clinical phenotypes were analyzed according to the distributions of allelic and genotypic frequencies and different genetic models. The odds ratio (OR) with corresponding 95% confidence interval (CI) was calculated. Among subjects with successfully genotyped, 107 participants suffered from ATDILI during follow-up. In BDKRB2, patients with rs79280755 G allele or rs117806152 C allele were more vulnerable to ATDILI (P-Bonferronicorrection=.002 and .03, respectively). Rs79280755 increased the risk of ATDILI significantly whether in additive (OR=3.218, 95% CI: 1.686-6.139, P-Bonferroni correction=.003) or dominant model (P-Bonferroni correction=.003), as well as rs117806152 (Additive model: P-Bonferroni (correction)=.05; dominant model: P-Bonferroni correction=.03). For TENM2, rs80003210 G allele contributed to the decreased risk of ATDILI (P-Bonferroni correction=.02), while rs2617972 A allele conferred susceptibility to ATDILI (P-Bonferroni correction=.01). Regarding rs2617972, significant findings were also observed in both additive (OR=3.203, 95% CI: 1.487-6.896, P-Bonferroni correction=.02) and dominant model (P-Bonferroni correction=.02). Moreover, rs79280755 and rs117806152 in BDKRB2 significantly affected some laboratory indicators. However, no meaningful SNPs were observed in TGFB2 and SLC2A13. Our study revealed that both BDKRB2 and TENM2 genetic polymorphisms were interrogated in relation to ATDILI susceptibility and some laboratory indicators in the Western Chinese Han population, shedding a new light on exploring novel biomarkers and targets for ATDILI.

NAT2 Polymorphisms and Susceptibility to Anti-Tuberculosis Drug-Induced Liver Injury: a Meta-Analysis [review Article]

Drug-metabolising Enzyme Polymorphisms and Predisposition to Anti-Tuberculosis Drug-Induced Liver Injury: a Meta-Analysis.

The relationship between polymorphisms of N-acetyltransferase 2 genes and anti-tuberculosis drug induced hepatic-injury

Pharmacogenetic Study Of Drug-Metabolising Enzyme Polymorphisms On The Risk Of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis

The Association of Genetic Polymorphisms of N-acetyltransferase 2 Gene with Hepatotoxicity and Efficacy in Chinese Han Patients with Tuberculosis

Vitamin E and lipid metabolism in man.

[Association of Rs1495741 Single Nucleotide Polymorphism with Susceptibility of Anti-tuberculosis Drug-induced Hepatotoxicity].

NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.

Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review

Meta-analysis on relationship between polymorphisms of CYP2E1 gene and susceptibility to antituberculosis druginduced liver injury

Influence of N-acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients

Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study

CYP2E1,GSTM1andGSTT1genetic Polymorphisms and Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity: a Nested Case-Control Study

Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.

The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.

CYP7A1, BAAT and UGT1A1 Polymorphisms and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity.

Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment

Association of CYP2B6 Gene Polymorphisms and Anti-Tuberculosis Drug-Induced Hepatotoxicity in a Chinese Population.

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Role of Polymorphic Bile Salt Export Pump (BSEP, ABCB11) Transporters in Anti-Tuberculosis Drug-Induced Liver Injury in a Chinese Cohort

Prospective Study Of Aldh1a1 Gene Polymorphisms Associated With Antituberculosis Drug-Induced Liver Injury In Western Chinese Han Population